Naomi Goldman
-
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 3
-
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 3
-
- Genomics and Chromatin Dynamics 4
- Epigenetics and DNA Methylation 2
- Co-authors
- Golnaz VahediSandra E. PikeT L GerrardGiovanna TosatoMaria FasolinoEric F. JoyceAditi ChandraSon C. Nguyen
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Immunity (2 papers)Molecular Cell (1 paper)
- Partner nations
- United StatesBrazil
In The Last Decade
Naomi Goldman
16 papers receiving 344 citations
Peers
Comparison fields: 5 of 52
- Immunology 147
- Oncology 93
- Molecular Biology 196
- Cancer Research 24
- Genetics 44
Countries citing papers authored by Naomi Goldman
This map shows the geographic impact of Naomi Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Goldman more than expected).
Fields of papers citing papers by Naomi Goldman
This network shows the impact of papers produced by Naomi Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Goldman. The network helps show where Naomi Goldman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naomi Goldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 17 | |
| 4 | 2023 | 12 | |
| 5 | 2022 | 40 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 42 | |
| 9 | 2020 | 35 | |
| 10 | 2019 | 73 | |
| 11 | 2019 | 25 | |
| 12 | 2018 | 8 | |
| 13 | 2017 | 13 | |
| 14 | 2017 | 5 | |
| 15 | 2016 | 14 | |
| 16 | 2016 | 1 | |
| 17 | 1988 | 58 |
About Naomi Goldman
Naomi Goldman is a scholar working on Immunology, Oncology and Hematology, having authored 17 papers that have together received 346 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Genomics and Chromatin Dynamics (4 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Immunology (147 citations), Oncology (93 citations) and Molecular Biology (196 citations). Naomi Goldman has collaborated with scholars based in United States and Brazil. Frequent co-authors include Golnaz Vahedi, Sandra E. Pike, T L Gerrard, Giovanna Tosato, Maria Fasolino, Eric F. Joyce, Aditi Chandra, Son C. Nguyen, James E. Riggs and Wenliang Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Immunity and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.